BioCentury | Jun 26, 2020
Politics, Policy & Law
Illumina, BGI litigation not yet at risk of getting drawn into U.S.-China dispute
...has previously found itself entangled in politics following its 2013 acquisition of U.S. sequencing company Complete Genomics Inc....
...In addition, BGI’s Complete Genomics subsidiary countersued Illumina in September, alleging that Illumina’s sequencing instruments infringe Complete Genomics’...
...In addition, BGI’s Complete Genomics subsidiary countersued Illumina in September, alleging that Illumina’s sequencing instruments infringe Complete Genomics’...